Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Diabliss Consumer Products Pvt Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. The actions are assigned to 2 distinct examiners and 2 distinct art units, indicating separate examination paths.
ALAM, AYAAN A is the busiest examiner, with 1 pending matter. The profile calls for examiner-specific preparation, with portfolio coordination limited to the shared technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPAINE, ROBERT FRANKLIN | 1 | 80.0% | +0.0% |
| ALAM, AYAAN A | 1 | 38.8% | +36.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258642 | A NUTRACEUTICALS FORMULATION WITH AN ENHANCED ORGANOLEPTIC PROPERTIES USED FOR SCALP AND HAIR CARE | SPAINE, ROBERT FRANKLIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258639 | A NUTRACEUTICALS FORMULATION FOR HYPERTENSION WITH ENHANCED ORGANOLEPTIC PROPERTIES | ALAM, AYAAN A | 40d |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18258642 | A NUTRACEUTICALS FORMULATION WITH AN ENHANCED ORGANOLEPTIC PROPERTIES USED FOR SCALP AND HAIR CARE | SPAINE, ROBERT FRANKLIN | 1600 | §101§103§112 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18258639 | A NUTRACEUTICALS FORMULATION FOR HYPERTENSION WITH ENHANCED ORGANOLEPTIC PROPERTIES | ALAM, AYAAN A | 1611 | §103 | Final Rejection | 40d | Pending | Jun 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDiabliss Consumer Products Pvt Ltd. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Robert Franklin Spaine has the most, with 1 of Diabliss Consumer Products Pvt Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.